SOURCE: Stock Market Alerts

September 19, 2007 08:20 ET

Hot Stock on the Move for Wednesday: RBRM! September 19, 2007

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts.

MIAMI, FL--(Marketwire - September 19, 2007) - Stock Market Alerts' performance stock list includes: ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM), Johnson & Johnson (NYSE: JNJ), Bristol-Myers Squibb Company (NYSE: BMY), Nanogen, Inc. (NASDAQ: NGEN).

Having just announced yesterday morning it has reached $1.5 million in sales, ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM) should have investors monitoring the stock closely as the company made its second announcement for Tuesday. The company, an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D, issued a press release Tuesday after the markets closed announcing the appointment of Foot-O-Pedics to be the exclusive distributor of its ReBuilder System for diabetic Peripheral Neuropathy in Maine.

Great news for RBRM investors! David B. Phillips, Ph.D., CEO of ReBuilder Medical Technologies, Inc. said, "We are pleased to add Foot-O-Pedics to our growing line of distributors and exclusively in Maine. They have a fantastic reputation and we have found that local representation and a personal demonstration lends credibility to our older customers who suffer from pain and tingling in their feet."

Foot-O-Pedics is a family-owned and operated business that prides itself in providing quality products and customer service. "We will commit to advertising the products in newspapers, TV and possibly radio," says Larry Gowell, President of Foot-O-Pedics. "We will also use direct mail to invite residents of Maine into our offices for a free demonstration of the ReBuilder."

In yesterday morning's press release, Daena Carter, Director of Accounting of ReBuilder Medical Technologies, Inc., stated, "It took us almost 4 years to reach $1 million in sales, and in 2007 alone, we have crossed the $1.5 million mark. These figures exceeded our 2006 target by 15% due to the infusion of international sales. Sales from foreign countries have increased by 15% in 2007. As a result we are actively seeking distributors and international representation for our products. The International Diabetes Federation estimates that over 230 million people worldwide now live with diabetes. Neuropathy is known to affect more than 30% of all diabetes sufferers."

ReBuilder Medical Technologies is certainly another company to watch closely! Last week, Rebuilder Medical Technologies reported to its board of directors that it has expanded its international customer base to include England, Canada, New Zealand and Australia. In a separate press release, the company also announced a marketing agreement with Affiliated Services, Inc. of Tampa, Florida. The marketing agreement enables Affiliated Services to market ReBuilder's products to the entire market of 155,000 physical therapists across the U.S..

Before the news was released, the stock closed Tuesday at Eighty Seven cents a share.

For Stock Market Alerts' in-depth profile of ReBuilder Medical Technologies, visit http://www.wallstreetenews.com/HotStocks/RBRM091807/default.aspx

The company is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical's flagship product is its FDA registered ReBuilder System for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.

Dr. Phillips is CEO of ReBuilder Medical Technologies, Inc. located in Charles Town, WV. He is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System for the early detection of breast cancer and the AcuPen which detects acupuncture points and then treats them.

Other Stocks of interest yesterday were:

Johnson & Johnson (NYSE: JNJ) up 1.4% on 12.6 million shares traded. Johnson & Johnson is a manufacturer of health care products.

Bristol-Myers Squibb Company (NYSE: BMY) up 2.9% on 16.6 million shares traded. Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

Nanogen, Inc. (NASDAQ: NGEN) even on 593,000 shares traded. Nanogen's advanced technologies provide researchers, clinicians and physicians with improved methods and tools to predict, diagnose, and ultimately help treat disease.

The advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company received compensation for services performed for ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM). The compensation is twenty four thousand dollars from third party, CLX & Associates, who is non-affiliated and may hold a significant position in the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.

The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.

This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Contact Information